Gilead Sciences
Gilead Sciences develops medicines for HIV, viral hepatitis, COVID-19, cancer, and inflammation.
10-QNov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
September 2026
August 2026
Gilead Sciences develops medicines for HIV, viral hepatitis, COVID-19, cancer, and inflammation.
November 2026
October 2026
September 2026
August 2026